DNMT3A and hematopoietic and lymphoid cell neoplasm: Likewise, our data reported here confirm that indeed, Flt3ITD/+ and bone marrow specific Dnmt3a deletion cooperate to result in shortened survival due to the development of fatal hematopoietic neoplasms, including AML and T-ALL.